http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56115716-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6abda2b86b4b1062ce675c4b3d37b3a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1980-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02c6f57a5e949708b177b7fc4b3847d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce702703b9fbd6b9accf1b0498a89434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2937df58a17a7d568f4e7246cb79da8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d04d8be4fd8f5f2d0a77ecaf3d6e4cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd5c89fb3106f27ec205a9f4687d930f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a6dfe7776a97aaf2c36a1c531a93bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f189c2dbf8118a87b8e3f3ee2fa1600
publicationDate 1981-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S56115716-A
titleOfInvention Immuno-chemotherapeutic, drug resistance preventing, carcinostatic agent
abstract PURPOSE: An immuno-chemotherapeutic, drug resistance preventing, carcinostatic agent containing a specific benzene derivative having a carbon-containing chain, as an effective component. n CONSTITUTION: A carcinostatic agent having remarkable immune-promoting and drug resistance preventing effects by itselt, is prepared by using a compound of formula (R 1 is H, OH, hydroxyalkoxy, phenoxy, alkyl, etc.; R 2 is H or OH; R 3 is H, OH, alkoxy, hydroxyalkyl, etc.; R 4 is H, OH, alkoxy, carboxyalkoxy, etc.; R 5 is H, OH, alkoxy, etc.; R 6 is H, OH, alkoxy, etc.) or its functional derivative (e.g. mandelic acid, 4-hydroxy-3-methoxymandelic acid, etc.), as an effective component. The agent exhibits an additive effect when used in combination with known carcinostatic agents, general antibiotics, and vaccines, and increases the antibacterial effects of these substances. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005187351-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110692636-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008100923-A
priorityDate 1980-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID736173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226507984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226502380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549439

Total number of triples: 40.